Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$46.82 - $76.2 $4,588 - $7,467
-98 Reduced 0.65%
14,865 $721,000
Q3 2022

Nov 14, 2022

BUY
$70.55 - $111.58 $752,415 - $1.19 Million
10,665 Added 248.14%
14,963 $1.06 Million
Q2 2022

Aug 12, 2022

BUY
$50.24 - $80.48 $215,931 - $345,903
4,298 New
4,298 $305,000
Q1 2022

May 13, 2022

SELL
$57.98 - $93.5 $2.06 Million - $3.32 Million
-35,458 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$88.02 - $127.79 $1.44 Million - $2.1 Million
-16,395 Reduced 31.62%
35,458 $3.24 Million
Q3 2021

Nov 15, 2021

SELL
$122.75 - $162.68 $207,815 - $275,417
-1,693 Reduced 3.16%
51,853 $6.67 Million
Q2 2021

Aug 16, 2021

SELL
$105.76 - $154.96 $669,672 - $981,206
-6,332 Reduced 10.57%
53,546 $8.17 Million
Q1 2021

May 14, 2021

BUY
$78.5 - $126.48 $789,317 - $1.27 Million
10,055 Added 20.18%
59,878 $6.31 Million
Q4 2020

Feb 02, 2021

BUY
$55.93 - $82.78 $697,894 - $1.03 Million
12,478 Added 33.41%
49,823 $3.95 Million
Q3 2020

Nov 05, 2020

SELL
$45.65 - $61.81 $833,386 - $1.13 Million
-18,256 Reduced 32.83%
37,345 $2.11 Million
Q2 2020

Jul 22, 2020

SELL
$29.15 - $61.54 $18,597 - $39,262
-638 Reduced 1.13%
55,601 $3.42 Million
Q1 2020

May 06, 2020

BUY
$25.01 - $42.4 $1.41 Million - $2.38 Million
56,239 New
56,239 $1.81 Million
Q3 2019

Nov 04, 2019

SELL
$25.78 - $34.8 $909,080 - $1.23 Million
-35,263 Closed
0 $0
Q2 2019

Jul 30, 2019

SELL
$23.08 - $37.01 $723,673 - $1.16 Million
-31,355 Reduced 47.07%
35,263 $1.04 Million
Q1 2019

May 09, 2019

SELL
$27.81 - $40.78 $943,370 - $1.38 Million
-33,922 Reduced 33.74%
66,618 $2.28 Million
Q4 2018

Feb 07, 2019

BUY
$28.91 - $50.0 $2.91 Million - $5.03 Million
100,540 New
100,540 $3.21 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.28B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.